The Centre for Commercialization of Regenerative Medicine (CCRM) Australia has partnered with local and international venture capital firms to launch the National Regenerative Medicine SuperPitch. The SuperPitch offers expertise and
Author: Ali Ranjbaran, Editor: Dr Chih Wei Teng Progress in medical science has always been driven by the need to overcome challenges and new threats to public health.
Regenerative Medicine: Impacts and lessons from COVID-19 Date: Thursday, 14th May 2020 Time: 12noon to 1pm AEST The effects of COVID-19 have been far reaching with negative impacts
The CCRM Australia team is modifying how we work and how we engage with those around us due to the evolving COVID-19 situation. We are well prepared to
CCRM Australia looks to the new decade with Australia as part of a worldwide regenerative medicine network without borders The coming decade is likely to bring significant advances
How CCRM Australia’s academic and industry partnerships helped an industry innovator connect with academic expertise and resources to deliver commercial-scale cell manufacturing. About Cynata Cynata is an Australian
Centre for Commercialization of Regenerative Medicine Australia (CCRM Australia) is proud to partner with St Vincent’s Health Service to form CCRM Australia Attract. CCRM Australia’s business unit will
The September 2019 issue of the CCRM Australia newsletter, #RegenMedAu, is now available to read. Here are some of the highlights for CCRM Australia in September: Sensors, the
Regenerative medicine is a risky business. The decades-long development pipeline and the expenditure of millions of dollars presents itself as an insurmountable mountain for many researchers. The regenerative
CCRM Australia has been helping early career researchers and high-achieving PhD candidates to gain the skills needed to commercialise and translate their regenerative medicine research into thriving business
